Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review

Hepatocellular carcinoma (HCC) remains one of the most common malignancies and the third cause of cancer-related death worldwide, with surgery being the best prognostic tool. Among the well-known causative factors of HCC are chronic liver virus infections, chronic virus hepatitis B (HBV) and chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Damaskos, Christos, Garmpis, Nikolaos, Dimitroulis, Dimitrios, Garmpi, Anna, Psilopatis, Iason, Sarantis, Panagiotis, Koustas, Evangelos, Kanavidis, Prodromos, Prevezanos, Dionysios, Kouraklis, Gregory, Karamouzis, Michail V., Marinos, Georgios, Kontzoglou, Konstantinos, Antoniou, Efstathios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698799/
https://www.ncbi.nlm.nih.gov/pubmed/36430594
http://dx.doi.org/10.3390/ijms232214117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698799/
https://www.ncbi.nlm.nih.gov/pubmed/36430594
http://dx.doi.org/10.3390/ijms232214117

Ejemplares similares